Background The Alberta Kidney Disease Network is a collaborative nephrology research
organization based on a central repository of laboratory and administrative data from the …

Background The effectiveness of various solutions instilled into the central venous catheter
lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of …

Results One hundred forty-five nephrologists participated in the survey (46% of the physician
membership of the Canadian Society of Nephrology). Nephrologists surveyed indicated …

Background: The RxEACH trial was a randomized trial to evaluate the efficacy of community
pharmacy-based case finding and intervention in patients at high risk for cardiovascular (CV…

Hyperhomocyst(e)inemia is now recognized as an independent risk factor for atherosclerotic
cardiovascular disease in patients with normal renal function. Hyperhomocyst(e)inemia is …

Background Adrenal vein sampling (AVS) is considered the gold-standard test to demonstrate
unilateral aldosterone excess in primary aldosteronism, yet no single approach to …

Results Among 96,480 adults with eGFR= 15–59 ml/min per 1.73 m 2, we found that 17.0%
of those without diabetes were appropriately risk stratified with a measure of albuminuria …

There are advantages to home dialysis for patients, and kidney care programs, but use
remains low in most countries. Health-care policy-makers have many levers to increase use of …

Results During a median follow-up of 3 years, 57,007 patients with CKD not on dialysis had
118,671 hospitalizations, of which 1.7% of patients were persistent high users, 12.3% were …

Background Vasodilator drugs have variable effects on veins and arteries. However, direct
measurements of their effects on the splanchnic veins, perhaps the most important volume …